SurModics Financials

SRDXDelisted Stock  USD 42.98  0.00  0.00%   
Based on the key indicators related to SurModics' liquidity, profitability, solvency, and operating efficiency, SurModics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.
  
Please note, the imprecision that can be found in SurModics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SurModics. Check SurModics' Beneish M Score to see the likelihood of SurModics' management manipulating its earnings.

SurModics Stock Summary

SurModics competes with Orthopediatrics Corp, Treace Medical, CeriBell, Semler Scientific, and Rxsight. Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS8688731004
Business Address9924 West 74th
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.surmodics.com
Phone952 500 7000
CurrencyUSD - US Dollar

SurModics Key Financial Ratios

SurModics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining SurModics's current stock value. Our valuation model uses many indicators to compare SurModics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SurModics competition to find correlations between indicators driving SurModics's intrinsic value. More Info.
SurModics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SurModics' earnings, one of the primary drivers of an investment's value.

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as SurModics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of SurModics has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if SurModics' financials are consistent with your investment objective using the following steps:
  • Review SurModics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand SurModics' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare SurModics' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if SurModics' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

SurModics January 9, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of SurModics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of SurModics. We use our internally-developed statistical techniques to arrive at the intrinsic value of SurModics based on widely used predictive technical indicators. In general, we focus on analyzing SurModics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build SurModics's daily price indicators and compare them against related drivers.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in SurModics Stock

If you are still planning to invest in SurModics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SurModics' history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios